Biolex Therapeutics Report issue

For profit Phase 2
Founded: Pittsboro NC United States (1997)
Status: Defunct (2012)

Organization Overview

First Clinical Trial
2008
NCT00593151
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Biolex Therapeutics, Inc.

Active Ingredients

Drugs in Phase 2 Trials (2)

interferon alpha-2b (Intron-A) (2 trials)

ribavirin (virazole) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hepatitis (Phase 2)

Hepatitis A (Phase 2)

Hepatitis C (Phase 2)

Hepatitis C, Chronic (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 2